Results from ALICE - Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple Negative Breast Cancer, a Randomized Phase IIb Trial

被引：0
|
作者：
Kyte, Jon Amund
Rossevold, Andreas H.
Andresen, Nikolai K.
Bjerre, Christina Annette
Gilje, Bjornar
Jakobsen, Erik Hugger
Raj, Sunil Xavier
Falk, Ragnhild Sorum
Borgen, Elin
Jahr, Thea
Garred, Oystein
Lomo, Jon
Mathiesen, Randi Margit
Naume, Bjorn
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-PD11-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD11-11
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Results From ALICE: Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer, a Randomized Phase IIb Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 9 - 9
  • [2] ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
    Kyte, J. A.
    Rossevold, A.
    Falk, R. S.
    Naume, B.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [3] ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
    J. A. Kyte
    A. Røssevold
    R. S. Falk
    B. Naume
    Journal of Translational Medicine, 18
  • [4] Phase I study combining ipatasertib with chemotherapy and atezolizumab in patients with metastatic triple negative breast cancer
    Yuan, Yuan
    Yost, Susan E.
    Lee, Jin Sun
    Frankel, Paul H.
    Ruel, Christopher
    Murga, Mireya
    Tang, Aileen
    Martinez, Norma
    Waisman, James
    Patel, Niki
    Sedrak, Mina
    Stewart, Daphne
    Lavasani, Sayeh
    Mortimer, Joanne
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
    Rossevold, Andreas Hagen
    Andresen, Nikolai Kragoe
    Bjerre, Christina Annette
    Gilje, Bjornar
    Jakobsen, Erik Hugger
    Raj, Sunil Xavier
    Falk, Ragnhild Sorum
    Russnes, Hege Giercksky
    Jahr, Thea
    Mathiesen, Randi Ruud
    Lomo, Jon
    Garred, Oystein
    Chauhan, Sudhir Kumar
    Lereim, Ragnhild Reehorst
    Dunn, Claire
    Naume, Bjorn
    Kyte, Jon Amund
    NATURE MEDICINE, 2022, 28 (12) : 2573 - +
  • [6] Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
    Andreas Hagen Røssevold
    Nikolai Kragøe Andresen
    Christina Annette Bjerre
    Bjørnar Gilje
    Erik Hugger Jakobsen
    Sunil Xavier Raj
    Ragnhild Sørum Falk
    Hege Giercksky Russnes
    Thea Jahr
    Randi Ruud Mathiesen
    Jon Lømo
    Øystein Garred
    Sudhir Kumar Chauhan
    Ragnhild Reehorst Lereim
    Claire Dunn
    Bjørn Naume
    Jon Amund Kyte
    Nature Medicine, 2022, 28 : 2573 - 2583
  • [7] ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
    J. A. Kyte
    N. K. Andresen
    H. G. Russnes
    S. Ø. Fretland
    R. S. Falk
    O. C. Lingjærde
    B. Naume
    Journal of Translational Medicine, 18
  • [8] ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
    Kyte, J. A.
    Andresen, N. K.
    Russnes, H. G.
    Fretland, S. O.
    Falk, R. S.
    Lingjaerde, O. C.
    Naume, B.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [9] IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer
    Cortes, Javier
    Andre, Fabrice
    Goncalves, Anthony
    Kuemmel, Sherko
    Martin, Miguel
    Schmid, Peter
    Schuetz, Florian
    Swain, Sandra M.
    Easton, Valerie
    Pollex, Erika
    Deurloo, Regula
    Dent, Rebecca
    FUTURE ONCOLOGY, 2019, 15 (17) : 1951 - 1961
  • [10] Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple negative breast cancer (mTNBC).
    Adams, Sylvia
    Diamond, Jennifer Robinson
    Hamilton, Erika Paige
    Pohlmann, Paula Raffin
    Tolaney, Sara M.
    Molinero, Luciana
    He, Xian
    Waterkamp, Daniel
    Funke, Roel Peter
    Powderly, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345